Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2022 | Challenges to be overcome in liquid biopsy

Amy Moore • 24 Oct 2022
ISLB 2022
Lung Cancer

Amy Moore, PhD, Lungevity Foundation, USA, discusses three key challenges that need to be overcome in liquid biopsy: the improvement of education and awareness of liquid biopsy among both patients and physicians, the improvement of access to liquid biopsy, and the addressing of cost issues. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Advisory Board: Bayer, Pfizer, Novartis, Exact Sciences, Jazz Pharmaceuticals, Debiopharm

More from Amy Moore

2:39
Current challenges for lung cancer patients due to COVID-19
Amy Moore • 24 Oct 2022
1:58
Unmet needs in lung cancer from a patient perspective
Amy Moore • 24 Oct 2022
3:35
Impact of COVID-19 on lung cancer diagnosis and treatment
Amy Moore • 18 Oct 2021
2:13
Future directions for lung cancer research
Amy Moore • 18 Oct 2021

Related Videos

2:38
Phase I trial of binimetinib and pembrolizumab in NSCLC
Natasha Leighl • 17 Apr 2024
2:43
CHRYSALIS: amivantamab in wild-type, pre-treated NSCLC
Natasha Leighl • 17 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
2:09
Is there a role for radiotherapy in extensive-stage SCLC?
Clive Peedell • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals